LSBio The Immunohistochemistry Antibody Company
  • Home
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
    • IHC-plus Antibodies
    • Isotype Control Antibodies
  • ELISA Kits
    • All Kits
    • Sandwich ELISA Kits
    • EIA Kits
    • Cell-Based ELISA Kits
    • Dna-Binding ELISA Kits
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Anti-MYL3 Antibody (aa1-30, PE) LS-C263844

Ordering

Wt. Vol. Conc. Price
- 200 µl - $545

LSBio (Direct) LSBio (Direct)
206-374-1102
866-206-6909
Orders@LSBio.com
 

100% Guaranteed 100% Guaranteed
Rabbit Polyclonal (IgG) to Human MYL3
Human
IHC, Western blot, ELISA
PE Conjugated

Details

Human MYL3
Rabbit
Human (tested or 100% immunogen sequence identity)
IgG Polyclonal
Phycoerythrin (PE)
Affinity purified

Applications

IHC, Western blot, ELISA

Specificity and Use

MYL3 antibody was raised against kLH-conjugated synthetic peptide (aa1-30) from the N-terminal region of human MYL3.
aa1-30
Human MYL3
The applications listed above are for the unconjugated form of this antibody. The conjugated antibody has not been tested.

Packaging

PBS, pH 7.2, 0.09% sodium azide.
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months.
For research use only.

About MYL3

P08590 NM_000258 NP_000249.1

MYL3 Antibody, CMH8 Antibody, Cardiac myosin light chain 1 Antibody, CMLC1 Antibody, Myosin, light chain 3, alkali Antibody, Myosin light chain 3 Antibody, Ventricular, skeletal, slow Antibody, VLC1 Antibody, MLC1SB Antibody, MLC1V Antibody

MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.

Requested From: United States
Date Requested: 9/18/2014

Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn
Copyright © 2014 LifeSpan BioSciences, Inc. All Rights Reserved